Minghui Pharmaceutical (hangzhou) Ltd

This study tested a new ointment called MH004 for people with mild to moderate eczema (atopic dermatitis). It involved 375 teenagers and adults who applied the ointment or a placebo cream twice daily for 8 weeks, followed by a longer safety period. The main goals were to see if t…

This early-stage study tested a new ointment called MH004 for people with mild to moderate atopic dermatitis (eczema). The first part checked the safety of different doses in healthy volunteers. The second part then tested if the ointment could reduce the severity of eczema rashe…